Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study

Abstract Background Treatment of Hepatitis C virus (HCV) infection has evolved from interferon (IFN)-based treatments to direct-acting antivirals (DAAs). Patients with HCV have an elevated psychiatric morbidity (including substance abuse) and patients with such comorbidity have often been excluded f...

Full description

Bibliographic Details
Main Authors: Isak Sundberg, Anders Lannergård, Mia Ramklint, Janet L. Cunningham
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Psychiatry
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12888-018-1735-6